May 12, 2020 / 10:30 AM / 20 days ago

BRIEF-Surface Oncology- As Of March 31, 2020, Cash, Cash Equivalents And Marketable Securities Were $90.1 Mln

May 12 (Reuters) - Surface Oncology Inc:

* SURFACE ONCOLOGY INC - AS OF MARCH 31, 2020, CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES WERE $90.1 MILLION

* SURFACE ONCOLOGY INC - REVENUE RECOGNIZED IN THREE MONTHS ENDED MARCH 31, 2020 WAS $38.6 MILLION, COMPARED TO $14.4 MILLION

* SURFACE ONCOLOGY INC - CONTINUES TO PROJECT THAT CURRENT CASH AND CASH EQUIVALENTS ARE SUFFICIENT TO FUND COMPANY INTO 2022

* SURFACE ONCOLOGY INC QTRLY EARNINGS PER SHARE $0.74 Source text: bit.ly/3dDP7OB Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below